Skip to main content

Table 4 Pooled resistance profile of enterococcal isolates in Ethiopia

From: Prevalence of Vancomycin resistant enterococci (VRE) in Ethiopia: a systematic review and meta-analysis

AntibioticsNo of studiesNo of enterococci isolates tested, NPooled resistance N, (%)95% CII2 (%)P-value
Amoxicillin2203115 (56.5)49.6–63.20.000.382
Amox-clavulanate222571 (45.3)13.9–80.992.37<  0.001
Ampicillin16807344 (44.5)29.2–61.090.83<  0.001
Chloramphenicol12777188 (32.9)20.8–47.887.24<  0.001
Ceftriaxone284 (50.0)20.0–80.00.00>  0.05
Ciprofloxacin17765266 (36.5)27.0–47.375.30<  0.001
Clindamycin422459 (26.9)21.5–33.20.000.478
Daptomycin2290.5 (3.2)a0.5–19.70.000.974
Doxycycline325485 (55.1)22.2–84.090.21<  0.001
Erythromycin14780374 (49.6)36.5–62.786.19<  0.001
Gentamycin10533248 (37.7)22.2–56.188.86<  0.001
Linezolid2302 (9.9)2.8–29.00.000.336
Nitrofurantoin9404117 (31.5)23.4–41.038.760.110
Norfloxacin5350100 (39.9)18.6–66.690.21<  0.001
Penicillin8343181 (60.7)39.9–78.386.63<  0.001
Streptomycin317974 (36.8)10.4–73.191.62<  0.001
Tetracycline9450199 (53.7)35.8–70.786.95<  0.001
SXT10241104 (39.1)21.48–59.645.580.088
MDR - enterococci20825543 (60.0)42.9–75.090.27<  0.001
  1. SXT Trimethoprim-Sulfamethoxazole, MDR Multidrug resistance
  2. a Continuity correction (0.5) is added to the study